Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Aug 26, 2022; 14(8): 454-461
Published online Aug 26, 2022. doi: 10.4330/wjc.v14.i8.454
Published online Aug 26, 2022. doi: 10.4330/wjc.v14.i8.454
SVEAT score outperforms HEART score in patients admitted to a chest pain observation unit
Daniel Antwi-Amoabeng, Moutaz Taha, Bryce David Beutler, Munadel Awad, Ahmed Hanfy, Jasmine Ghuman, Nicholas T Manasewitsch, Sahajpreet Singh, Claire Quang, Nageshwara Gullapalli, Department of Internal Medicine, Reno School of Medicine, University of Nevada, Reno, NV 89502, United States
Chanwit Roongsritong, Institute for Heart and Vascular Health, Renown Regional Medical Center, Reno, NV 89502, United States
Author contributions: Antwi-Amoabeng D and Roongsritong C helped design the research study and wrote the original draft of the manuscript; Taha M, Beutler BD, Awad M and Hanfy A contributed to data curation, validation, and formal analysis; Ghuman J, Manasewitsch NT, Singh S and Quang C contributed to data curation and helped review and edit the manuscript; Gullapalli N supervised the project from initiation to completion.
Institutional review board statement: The study protocol was reviewed and approved by the University of Nevada, Reno School of Medicine Institutional Review Board.
Informed consent statement: The study was conducted in accordance with the policies of the Institutional Review Board of the University of Nevada, Reno School of Medicine. The trial was conducted as a retrospective cohort study using anonymized data from existing records. Therefore, informed consent was not required.
Conflict-of-interest statement: The authors declare no actual or potential conflicts of interest or relationship with industry.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author upon reasonable request.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bryce David Beutler, MD, Doctor, Department of Internal Medicine, University of Nevada, Reno School of Medicine, 1155 Mill Street W-11, Reno, Nevada 89502, United States. brycebeutler@hotmail.com
Received: October 21, 2021
Peer-review started: October 23, 2021
First decision: April 7, 2022
Revised: May 21, 2022
Accepted: August 5, 2022
Article in press: August 5, 2022
Published online: August 26, 2022
Processing time: 299 Days and 10.2 Hours
Peer-review started: October 23, 2021
First decision: April 7, 2022
Revised: May 21, 2022
Accepted: August 5, 2022
Article in press: August 5, 2022
Published online: August 26, 2022
Processing time: 299 Days and 10.2 Hours
Core Tip
Core Tip: Most chest pain risk stratification scores do not use several readily available data. The Symptoms, history of Vascular disease, Electrocardiography, Age, and Troponin (SVEAT) score was shown to outperform the History, Electrocardiography, Age, Risk factors and Troponin (HEART) score in 30-d major adverse cardiovascular event. In our retrospective cohort study, we validated the performance of the SVEAT score and confirmed that the SVEAT score is superior to the HEART score as a risk stratification tool for acute chest pain in low to intermediate risk patients.